Are you Dr. Singer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8800Fax+1 214-645-8801
Summary
- Dr. Mike Singer, MD is a board certified neurologist in Dallas, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Parkland Health and is an Assistant Professor at University of Texas Southwestern Medical Center.
Education & Training
University of ChicagoResidency, Neurology, 2001 - 2004- University of ChicagoInternship, Internal Medicine, 2000 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000
Certifications & Licensure
TX State Medical License 2005 - 2026- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 4 citationsAn unusual case of Miller Fisher syndrome presenting with proptosis and chemosis.Maggie W. Waung, Mike A. Singer
Muscle & Nerve. 2012-05-01 - 48 citationsReversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review.Mike A. Singer, Christos Lazaridis, Sharon P. Nations, Gil I. Wolfe
Muscle & Nerve. 2008-01-01 - 37 citationsIdiopathic neuropathy: new paradigms, new promiseMike A. Singer, Steven Vernino, Gil I. Wolfe
Journal of the Peripheral Nervous System. 2012-05-01
Press Mentions
FDA Advisers Narrowly Endorse First Gene Therapy for Muscular DystrophyMay 12th, 2023- FDA Advisers Narrowly Back First Gene Therapy for Muscular DystrophyMay 12th, 2023
